## LITE: Lumentum Holdings Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 1.2% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-10.2% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($283.55)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Lumentum adds onsemi (NASDAQ: ON) CFO Thad Trent to expand board to nine members**
- Source: Stock Titan | 20251216T100936 | Bullish | Relevance: 100%
- Lumentum Holdings Inc. announced the appointment of Thad Trent, CFO of onsemi (NASDAQ: ON), to its Board of Directors, expanding the board to nine members. Trent brings extensive expertise in corporate finance, M&A, and manufacturing, which Lumentum expects to be crucial for its growth and long-term strategy. His appointment is aimed at leveraging his insights to capitalize on opportunities in artificial intelligence and cloud infrastructure.

**2. LMR Partners LLP Buys New Shares in Lumentum Holdings Inc. $LITE**
- Source: MarketBeat | 20251214T140921 | Bullish | Relevance: 100%
- LMR Partners LLP has acquired 127,000 shares of Lumentum Holdings Inc. (NASDAQ:LITE) during Q2, a new position valued at approximately $12.07 million. This purchase represents about 0.18% of the company, which recently exceeded quarterly earnings estimates and issued strong guidance. The company maintains a "Moderate Buy" consensus from Wall Street with an average target price of $215.

**3. Cim Investment Management Inc. Raises Position in Lumentum Holdings Inc. $LITE**
- Source: MarketBeat | 20251214T102029 | Somewhat-Bullish | Relevance: 100%
- Cim Investment Management Inc. significantly increased its stake in Lumentum Holdings Inc. by 100.8%, now owning 9,622 shares valued at $860,000. Despite this, insiders have been net sellers, disposing of over $7.3 million worth of shares, and the company reported stronger-than-expected earnings of $1.10 EPS against a $1.03 estimate, with revenue up 58.4% year-over-year. Lumentum provided optimistic Q2 2026 guidance and holds a "Moderate Buy" consensus rating with a $215 price target.

**4. Lumentum Holdings Inc. $LITE Shares Sold by Castleark Management LLC**
- Source: MarketBeat | 20251214T100929 | Neutral | Relevance: 100%
- Castleark Management LLC significantly reduced its stake in Lumentum Holdings Inc. ($LITE) by 34.1% in Q2, selling 32,740 shares, while company insiders have also been net sellers. Despite insider selling, Lumentum beat quarterly earnings estimates and provided strong Q2 2026 guidance, maintaining a "Moderate Buy" consensus rating among analysts with a target price of $215. The stock shows strong price performance, trading near recent highs with a $23 billion market cap.

**5. Is It Time To Consider Buying Lumentum Holdings Inc. (NASDAQ:LITE)?**
- Source: 富途牛牛 | 20251214T000929 | Neutral | Relevance: 100%
- Lumentum Holdings Inc. (NASDAQ:LITE) shares recently saw a significant price hike, yet the stock is considered overvalued by 38% compared to its intrinsic value of $235.03. Despite this, the future outlook for Lumentum Holdings appears bright with expected profit doubling over the next couple of years, suggesting higher cash flow and a potentially higher share valuation. Investors are advised to consider the current overvaluation and potential volatility, but also the positive future growth prospects.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Rosenblatt | $380 | $280 | +36% |
| 2025-11-25 | Mizuho | $325 | $290 | +12% |
| 2025-11-24 | Rosenblatt | $280 | $280 | 0% |
| 2025-11-24 | Needham | $290 | $235 | +23% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Rosenblatt | main | Buy |
| 2025-11-25 | Mizuho | main | Outperform |
| 2025-11-24 | Rosenblatt | main | Buy |
| 2025-11-24 | Needham | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 7 ($0.00M) |
| Sells | 14 ($9.53M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Blackrock Inc.: 11.2% (+7.6%)
- Vanguard Group Inc: 10.6% (+0.6%)
- FMR, LLC: 8.4% (-10.6%)
- Capital World Invest: 5.7% (-29.3%)
- Invesco Ltd.: 3.2% (-41.6%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-10.2% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $9.5M in recent transactions.
3. High short interest (20.1%, 2.3 days to cover): squeeze risk or crowded bearish bet.

### Catalysts

- Analyst target momentum: 3 raises (avg +24%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.97 indicates undervaluation relative to growth. Forward P/E 40.9x attractive for 44% earnings growth. Revenue growth strong at 31% YoY. Analyst sentiment positive (3 raises, avg +24%). Insider selling cluster ($9.5M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $23.7B |
| Beta | 1.53 |
| 52W Range | $45.65 - $376.53 |
| Short Interest | 20.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.97 |
| Forward P/E | 40.9 |
| Current P/E | 58.8 |
| YoY Growth | 43.9% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 11.4% to 1.2% (-10.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.8pp (needs >3.0% for momentum thesis). MRS_5 (-3.3%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-0.69), momentum weakening. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.20% (CS: 38) | Neutral |
| RSI_14 | 60.3 | Neutral |
| MACD Histogram | -0.69 | Bearish |
| vs SMA20 | 1.088x | Above |
| vs SMA50 | 1.405x | Above |
| vs SMA200 | 2.559x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $334.69
- **Stop Loss:** $283.55 (15.3% risk)
- **Target:** $385.83 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 19
- **Position Value:** $6,359.11
- **Portfolio %:** 6.36%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-05 (Est: $1.38)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.03 | $1.10 | +7.0% |
| 2025Q2 | $0.81 | $0.88 | +8.9% |
| 2025Q1 | $0.50 | $0.57 | +13.7% |
| 2024Q4 | $0.36 | $0.42 | +17.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*